Related Experiment Videos
Prostate cancer gene therapy: outcome of basic research and clinical trials
Y Nasu1, B Djavan, M Marberger
1Department of Urology, Okayama University Medical School, Japan.
Abstract:
With the advances in genetic engineering, tumor biology, and immunology, gene therapy has been recognized as a promising new treatment option for cancer, including prostate cancer. Several clinical trials of prostate cancer gene therapy currently underway are using therapeutic genes, including suicide genes, immunomodulatory genes, tumor suppressor genes, and antioncogenes. Although gene therapy for prostate cancer as a clinical alternative is still at an early stage that requires several technological breakthroughs, information obtained from clinical trials indicates the full potential of prostate cancer gene therapy. Concordant progress in basic research and gene therapy technology will ready prostate cancer gene therapy for widescale use in the future. In this report, the general concept and current progress in prostate cancer gene therapy are summarized.
Insights
Gene therapy shows promise for prostate cancer treatment, utilizing various therapeutic genes in ongoing clinical trials. Further advancements are needed for widespread clinical application.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Gene therapy is emerging as a potential cancer treatment, particularly for prostate cancer.
- Advances in genetic engineering, tumor biology, and immunology support its development.
Purpose of the Study:
- To summarize the general concept of gene therapy for prostate cancer.
- To review the current progress of prostate cancer gene therapy.
Main Methods:
- Review of current clinical trials for prostate cancer gene therapy.
- Analysis of therapeutic gene categories used in trials.
Main Results:
- Clinical trials are investigating suicide genes, immunomodulatory genes, tumor suppressor genes, and antioncogenes.
- Early-stage clinical data suggest significant potential for prostate cancer gene therapy.
Conclusions:
- Prostate cancer gene therapy requires further technological breakthroughs for clinical use.
- Integrated progress in basic research and gene therapy technology will enable future widespread application.